InstitutionMD Anderson
DepartmentCancer Biology
Address7777 Knight Rd
Houston TX 77054-3005
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Peng K, Shen YP, Ying YY, Kiaii B, Rodriguez V, Boyd D, Applegate RL, Lubarsky DA, Zhang Z, Xia Z, Feng XM, Yang JP, Liu H, Ji FH. Perioperative dexmedetomidine and 5-year survival in patients undergoing cardiac surgery. Br J Anaesth. 2021 May 31. PMID: 34082896.
      Citations:    Fields:    
    2. Budde D, Hinkelbein J, Boyd DD. Analysis of Air Taxi Accidents (20042018) and Associated Human Factors by Aircraft Performance Class. Aerosp Med Hum Perform. 2021 May 01; 92(5):294-302. PMID: 33875061.
      Citations:    Fields:    
    3. Boyd DD, Scharf M, Cross D. A comparison of general aviation accidents involving airline pilots and instrument-rated private pilots. J Safety Res. 2021 02; 76:127-134. PMID: 33653543.
      Citations:    Fields:    Translation:Humans
    4. Boyd DD, Howell C. Accident Rates, Causes, and Occupant Injury Involving High-Performance General Aviation Aircraft. Aerosp Med Hum Perform. 2020 May 01; 91(5):387-393. PMID: 32327011.
      Citations:    Fields:    Translation:Humans
    5. Boyd DD. Occupant Injury Severity in General Aviation Accidents Involving Excessive Landing Airspeed. Aerosp Med Hum Perform. 2019 Apr 01; 90(4):355-361. PMID: 30922422.
      Citations:    Fields:    Translation:Humans
    6. Boyd DD. General Aviation Accidents Involving Octogenarian Airmen: Implications for Medical Evaluation. Aerosp Med Hum Perform. 2018 Aug 01; 89(8):687-692. PMID: 30020052.
      Citations:    Fields:    Translation:Humans
    7. Anderson C, Stolzer A, Boyd DD. A comparison of special category light-sport and corresponding type-certificated aircraft safety. J Safety Res. 2018 Sep; 66:95-99. PMID: 30121116.
      Citations:    Fields:    
    8. Boyd DD. In-Flight Decision-Making by General Aviation Pilots Operating in Areas of Extreme Thunderstorms. Aerosp Med Hum Perform. 2017 Dec 01; 88(12):1066-1072. PMID: 29157334.
      Citations: 1     Fields:    Translation:Humans
    9. Boyd DD. A Review of General Aviation Safety (1984-2017). Aerosp Med Hum Perform. 2017 Jul 01; 88(7):657-664. PMID: 28641683.
      Citations: 1     Fields:    Translation:Humans
    10. Aguiar M, Stolzer A, Boyd DD. Rates and causes of accidents for general aviation aircraft operating in a mountainous and high elevation terrain environment. Accid Anal Prev. 2017 Oct; 107:195-201. PMID: 28532572.
      Citations:    Fields:    Translation:Humans
    11. Boyd D, Hart J. Potential Utility of a Cost-Effective Virtual Reality System for Treatment of Fear of Flying. Aerosp Med Hum Perform. 2016 Sep; 87(9):830-2. PMID: 27634706.
      Citations:    Fields:    Translation:Humans
    12. Boyd DD. General aviation accidents related to exceedance of airplane weight/center of gravity limits. Accid Anal Prev. 2016 Jun; 91:19-23. PMID: 26945473.
      Citations:    Fields:    Translation:Humans
    13. Boyd DD, Macchiarella ND. Occupant Injury Severity and Accident Causes in Helicopter Emergency Medical Services (1983-2014). Aerosp Med Hum Perform. 2016 Jan; 87(1):26-31. PMID: 26735230.
      Citations:    Fields:    Translation:Humans
    14. Boyd DD, Stolzer A. Accident-precipitating factors for crashes in turbine-powered general aviation aircraft. Accid Anal Prev. 2016 Jan; 86:209-16. PMID: 26590507.
      Citations:    Fields:    Translation:Humans
    15. Boyd DD, Peters C. Should Charity Air Medical Organizations Require Commercial Certification of Their Pilots? Air Med J. 2015 Jul-Aug; 34(4):188-94. PMID: 26206543.
      Citations:    Fields:    Translation:Humans
    16. Boyd DD. Occupant injury and fatality in general aviation aircraft for which dynamic crash testing is certification-mandated. Accid Anal Prev. 2015 Jun; 79:182-9. PMID: 25838192.
      Citations:    Fields:    Translation:Humans
    17. Boyd DD. Causes and risk factors for fatal accidents in non-commercial twin engine piston general aviation aircraft. Accid Anal Prev. 2015 Apr; 77:113-9. PMID: 25701648.
      Citations:    Fields:    Translation:Humans
    18. Shao BS, Guindani M, Boyd DD. Causes of fatal accidents for instrument-certified and non-certified private pilots. Accid Anal Prev. 2014 Nov; 72:370-5. PMID: 25118128.
      Citations:    Fields:    Translation:Humans
    19. Shao BS, Guindani M, Boyd DD. Fatal accident rates for instrument-rated private pilots. Aviat Space Environ Med. 2014 Jun; 85(6):631-7. PMID: 24919384.
      Citations: 1     Fields:    Translation:Humans
    20. Boyd D, Wetterneck C, Hart J. Potential utility of full motion flight simulators for treatment of individuals with a fear of flying. Aviat Space Environ Med. 2013 Mar; 84(3):264-5. PMID: 23513291.
      Citations:    Fields:    Translation:Humans
    21. Chauhan S, Goodwin JG, Chauhan S, Manyam G, Wang J, Kamat AM, Boyd DD. ZKSCAN3 is a master transcriptional repressor of autophagy. Mol Cell. 2013 Apr 11; 50(1):16-28. PMID: 23434374.
      Citations: 91     Fields:    Translation:HumansCells
    22. Kim J, Ebertowski J, Janiga M, Arzola J, Gillespie G, Fountain M, Soderdahl D, Canby-Hagino E, Elsamanoudi S, Gurski J, Davis JW, Parker PA, Boyd DD. Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance. BJU Int. 2013 May; 111(6):934-40. PMID: 23350937.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    23. Rogers D, Boyd DD, Fox EE, Cooper S, Goldhagen M, Shen Y, Del Junco DJ. Prostate cancer incidence in U.S. Air Force aviators compared with non-aviators. Aviat Space Environ Med. 2011 Nov; 82(11):1067-70. PMID: 22097644.
      Citations: 3     Fields:    Translation:Humans
    24. Chauhan S, Boyd DD. Regulation of u-PAR gene expression by H2A.Z is modulated by the MEK-ERK/AP-1 pathway. Nucleic Acids Res. 2012 Jan; 40(2):600-13. PMID: 21937508.
      Citations: 7     Fields:    Translation:HumansCells
    25. del Junco DJ, Fox EE, Cooper S, Goldhagen M, Koda E, Rogers D, Canby-Hagino E, Kim J, Pettaway C, Boyd DD. Increasing low risk prostate cancer incidence in United States Air Force servicemen and selection of treatments. J Urol. 2011 Jun; 185(6):2137-42. PMID: 21496842.
      Citations:    Fields:    Translation:Humans
    26. Avila H, Wang H, Chauhan S, Hartig S, Boyd DD. Accelerated urokinase-receptor protein turnover triggered by interference with the addition of the glycolipid anchor. Biochem J. 2011 Mar 01; 434(2):233-42. PMID: 21143195.
      Citations: 1     Fields:    Translation:HumansCells
    27. Mo P, Wang H, Lu H, Boyd DD, Yan C. MDM2 mediates ubiquitination and degradation of activating transcription factor 3. J Biol Chem. 2010 Aug 27; 285(35):26908-26915. PMID: 20592017.
      Citations: 21     Fields:    Translation:HumansAnimalsCells
    28. Ishiguro T, Avila H, Lin SY, Nakamura T, Yamamoto M, Boyd DD. Gene trapping identifies chloride channel 4 as a novel inducer of colon cancer cell migration, invasion and metastases. Br J Cancer. 2010 Feb 16; 102(4):774-82. PMID: 20087350.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    29. Yang L, Zhang L, Wu Q, Boyd DD. Unbiased screening for transcriptional targets of ZKSCAN3 identifies integrin beta 4 and vascular endothelial growth factor as downstream targets. J Biol Chem. 2008 Dec 12; 283(50):35295-304. PMID: 18940803.
      Citations: 21     Fields:    Translation:HumansAnimalsCells
    30. Yang L, Hamilton SR, Sood A, Kuwai T, Ellis L, Sanguino A, Lopez-Berestein G, Boyd DD. The previously undescribed ZKSCAN3 (ZNF306) is a novel "driver" of colorectal cancer progression. Cancer Res. 2008 Jun 01; 68(11):4321-30. PMID: 18519692.
      Citations: 27     Fields:    Translation:HumansAnimalsCells
    31. Nair RR, Avila H, Ma X, Wang Z, Lennartz M, Darnay BG, Boyd DD, Yan C. A novel high-throughput screening system identifies a small molecule repressive for matrix metalloproteinase-9 expression. Mol Pharmacol. 2008 Mar; 73(3):919-29. PMID: 18065684.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    32. Yan C, Boyd DD. Regulation of matrix metalloproteinase gene expression. J Cell Physiol. 2007 Apr; 211(1):19-26. PMID: 17167774.
      Citations: 228     Fields:    Translation:HumansAnimalsCells
    33. Qi W, Wu H, Yang L, Boyd DD, Wang Z. A novel function of caspase-8 in the regulation of androgen-receptor-driven gene expression. EMBO J. 2007 Jan 10; 26(1):65-75. PMID: 17170703.
      Citations: 7     Fields:    Translation:HumansCells
    34. Wang H, Yan C, Asangani I, Allgayer H, Boyd DD. Identification of an histone H3 acetylated/K4-methylated-bound intragenic enhancer regulatory for urokinase receptor expression. Oncogene. 2007 Mar 29; 26(14):2058-70. PMID: 17001307.
      Citations: 4     Fields:    Translation:HumansCells
    35. Yan C, Boyd DD. Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression. Mol Cell Biol. 2006 Sep; 26(17):6357-71. PMID: 16914722.
      Citations: 64     Fields:    Translation:HumansCells
    36. Yang L, Avila H, Wang H, Trevino J, Gallick GE, Kitadai Y, Sasaki T, Boyd DD. Plasticity in urokinase-type plasminogen activator receptor (uPAR) display in colon cancer yields metastable subpopulations oscillating in cell surface uPAR density--implications in tumor progression. Cancer Res. 2006 Aug 15; 66(16):7957-67. PMID: 16912170.
      Citations: 6     Fields:    Translation:HumansCells
    37. Nair RR, Solway J, Boyd DD. Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression. J Biol Chem. 2006 Sep 08; 281(36):26424-36. PMID: 16835221.
      Citations: 45     Fields:    Translation:HumansAnimalsCells
    38. Yan C, Boyd DD. ATF3 regulates the stability of p53: a link to cancer. Cell Cycle. 2006 May; 5(9):926-9. PMID: 16628010.
      Citations: 30     Translation:HumansCells
    39. Nair RR, Boyd DD. Expression cloning of novel regulators of 92 kDa type IV collagenase expression. Biochem Soc Trans. 2005 Nov; 33(Pt 5):1135-6. PMID: 16246065.
      Citations: 3     Fields:    Translation:HumansCells
    40. Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Cancer Res. 2005 Sep 01; 65(17):7775-81. PMID: 16140945.
      Citations: 47     Fields:    Translation:HumansAnimalsCells
    41. Yan C, Lu D, Hai T, Boyd DD. Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J. 2005 Jul 06; 24(13):2425-35. PMID: 15933712.
      Citations: 72     Fields:    Translation:HumansAnimalsCells
    42. Yan C, Jamaluddin MS, Aggarwal B, Myers J, Boyd DD. Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol Cancer Ther. 2005 Feb; 4(2):233-41. PMID: 15713895.
      Citations: 36     Translation:HumansCells
    43. Nair RR, Wang H, Jamaluddin MS, Fokt I, Priebe W, Boyd DD. A bisanthracycline (WP631) represses uPAR gene expression and cell migration of RKO colon cancer cells by interfering with transcription factor binding to a chromatin-accessible -148/-124 promoter region. Oncol Res. 2005; 15(5):265-79. PMID: 16261846.
      Citations: 1     Fields:    Translation:HumansCells
    44. Borgatti M, Boyd DD, Lampronti I, Bianchi N, Fabbri E, Saviano M, Romanelli A, Pedone C, Gambari R. Decoy molecules based on PNA-DNA chimeras and targeting Sp1 transcription factors inhibit the activity of urokinase-type plasminogen activator receptor (uPAR) promoter. Oncol Res. 2005; 15(7-8):373-83. PMID: 16491955.
      Citations: 5     Fields:    Translation:HumansCells
    45. Hill DA, Chiosea S, Jamaluddin S, Roy K, Fischer AH, Boyd DD, Nickerson JA, Imbalzano AN. Inducible changes in cell size and attachment area due to expression of a mutant SWI/SNF chromatin remodeling enzyme. J Cell Sci. 2004 Nov 15; 117(Pt 24):5847-54. PMID: 15537831.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    46. Boyd DD, Nakajima M. Involvement of heparanase in tumor metastases: a new target in cancer therapy? J Natl Cancer Inst. 2004 Aug 18; 96(16):1194-5. PMID: 15316047.
      Citations: 5     Fields:    Translation:Humans
    47. Takada Y, Fang X, Jamaluddin MS, Boyd DD, Aggarwal BB. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor. J Biol Chem. 2004 Sep 17; 279(38):39541-54. PMID: 15252041.
      Citations: 67     Fields:    Translation:AnimalsCells
    48. Wang H, Yang L, Jamaluddin MS, Boyd DD. The Kruppel-like KLF4 transcription factor, a novel regulator of urokinase receptor expression, drives synthesis of this binding site in colonic crypt luminal surface epithelial cells. J Biol Chem. 2004 May 21; 279(21):22674-83. PMID: 15031282.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    49. Boyd DD, Wang H, Avila H, Parikh NU, Kessler H, Magdolen V, Gallick GE. Combination of an SRC kinase inhibitor with a novel pharmacological antagonist of the urokinase receptor diminishes in vitro colon cancer invasiveness. Clin Cancer Res. 2004 Feb 15; 10(4):1545-55. PMID: 14977859.
      Citations: 10     Fields:    Translation:HumansCells
    50. Yan C, Wang H, Aggarwal B, Boyd DD. A novel homologous recombination system to study 92 kDa type IV collagenase transcription demonstrates that the NF-kappaB motif drives the transition from a repressed to an activated state of gene expression. FASEB J. 2004 Mar; 18(3):540-1. PMID: 14715692.
      Citations: 17     Fields:    Translation:HumansCells
    51. Wang H, Hicks J, Khanbolooki P, Kim SJ, Yan C, Wang Y, Boyd D. Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene. Am J Pathol. 2003 Aug; 163(2):453-64. PMID: 12875967.
      Citations: 2     Fields:    Translation:AnimalsCells
    52. Schewe DM, Leupold JH, Boyd DD, Lengyel ER, Wang H, Gruetzner KU, Schildberg FW, Jauch KW, Allgayer H. Tumor-specific transcription factor binding to an activator protein-2/Sp1 element of the urokinase-type plasminogen activator receptor promoter in a first large series of resected gastrointestinal cancers. Clin Cancer Res. 2003 Jun; 9(6):2267-76. PMID: 12796395.
      Citations: 4     Fields:    Translation:HumansCells
    53. Boyd DD, Kim SJ, Wang H, Jones TR, Gallick GE. A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis. Am J Pathol. 2003 Feb; 162(2):619-26. PMID: 12547719.
      Citations: 20     Fields:    Translation:Animals
    54. Semere WG, Edwards TM, Boyd D, Barsoumian R, Murero M, Donias HW, Karamanoukian HL. The world wide web and robotic heart surgery. Heart Surg Forum. 2003; 6(6):E111-9. PMID: 14721995.
      Citations: 1     Fields:    Translation:Humans
    55. Yan C, Wang H, Toh Y, Boyd DD. Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation. J Biol Chem. 2003 Jan 24; 278(4):2309-16. PMID: 12431981.
      Citations: 27     Fields:    Translation:HumansCells
    56. Lakka SS, Jasti SL, Gondi C, Boyd D, Chandrasekar N, Dinh DH, Olivero WC, Gujrati M, Rao JS. Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene. 2002 Aug 15; 21(36):5601-8. PMID: 12165859.
      Citations: 35     Fields:    Translation:HumansCells
    57. Sancéau J, Boyd DD, Seiki M, Bauvois B. Interferons inhibit tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-kappa B. J Biol Chem. 2002 Sep 20; 277(38):35766-75. PMID: 12105194.
      Citations: 24     Fields:    Translation:HumansCells
    58. Shin M, Yan C, Boyd D. An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression. Biochim Biophys Acta. 2002 May 08; 1589(3):311-6. PMID: 12031798.
      Citations: 40     Fields:    Translation:HumansCells
    59. Aligayer H, Boyd DD, Heiss MM, Abdalla EK, Curley SA, Gallick GE. Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis. Cancer. 2002 Jan 15; 94(2):344-51. PMID: 11900220.
      Citations: 100     Fields:    Translation:HumansCells
    60. Yan C, Wang H, Boyd DD. ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter. J Biol Chem. 2002 Mar 29; 277(13):10804-12. PMID: 11792711.
      Citations: 34     Fields:    Translation:HumansCells
    61. Bhattacharya A, Lakka SS, Mohanam S, Boyd D, Rao JS. Regulation of the urokinase-type plasminogen activator receptor gene in different grades of human glioma cell lines. Clin Cancer Res. 2001 Feb; 7(2):267-76. PMID: 11234878.
      Citations: 4     Fields:    Translation:HumansCells
    62. Yan C, Wang H, Boyd DD. KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation. J Biol Chem. 2001 Jan 12; 276(2):1164-72. PMID: 11060311.
      Citations: 59     Fields:    Translation:HumansCells
    63. Lakka SS, Bhattacharya A, Mohanam S, Boyd D, Rao JS. Regulation of the uPA gene in various grades of human glioma cells. Int J Oncol. 2001 Jan; 18(1):71-9. PMID: 11115541.
      Citations: 8     Fields:    Translation:HumansCells
    64. Mazumdar A, Adam L, Boyd D, Kumar R. Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion. Cancer Res. 2001 Jan 01; 61(1):400-5. PMID: 11196194.
      Citations: 11     Fields:    Translation:HumansCells
    65. Wang Y, Dang J, Wang H, Allgayer H, Murrell GA, Boyd D. Identification of a novel nuclear factor-kappaB sequence involved in expression of urokinase-type plasminogen activator receptor. Eur J Biochem. 2000 Jun; 267(11):3248-54. PMID: 10824110.
      Citations: 18     Fields:    Translation:HumansCells
    66. Fang X, Yu S, Eder A, Mao M, Bast RC, Boyd D, Mills GB. Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway. Oncogene. 1999 Nov 18; 18(48):6635-40. PMID: 10597268.
      Citations: 87     Fields:    Translation:HumansAnimalsCells
    67. Dang J, Boyd D, Wang H, Allgayer H, Doe WF, Wang Y. A region between -141 and -61 bp containing a proximal AP-1 is essential for constitutive expression of urokinase-type plasminogen activator receptor. Eur J Biochem. 1999 Aug; 264(1):92-9. PMID: 10447677.
      Citations: 8     Fields:    Translation:HumansCells
    68. Allgayer H, Wang H, Shirasawa S, Sasazuki T, Boyd D. Targeted disruption of the K-ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysis. Br J Cancer. 1999 Aug; 80(12):1884-91. PMID: 10471035.
      Citations: 8     Fields:    Translation:HumansCells
    69. Simon C, Hicks MJ, Nemechek AJ, Mehta R, O'Malley BW, Goepfert H, Flaitz CM, Boyd D. PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma. Br J Cancer. 1999 Jul; 80(9):1412-9. PMID: 10424744.
      Citations: 8     Fields:    Translation:HumansAnimals
    70. Zucker S, Hymowitz M, Conner C, Zarrabi HM, Hurewitz AN, Matrisian L, Boyd D, Nicolson G, Montana S. Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications. Ann N Y Acad Sci. 1999 Jun 30; 878:212-27. PMID: 10415733.
      Citations: 51     Fields:    Translation:HumansCells
    71. Allgayer H, Wang H, Gallick GE, Crabtree A, Mazar A, Jones T, Kraker AJ, Boyd DD. Transcriptional induction of the urokinase receptor gene by a constitutively active Src. Requirement of an upstream motif (-152/-135) bound with Sp1. J Biol Chem. 1999 Jun 25; 274(26):18428-37. PMID: 10373450.
      Citations: 11     Fields:    Translation:HumansCells
    72. Allgayer H, Wang H, Wang Y, Heiss MM, Bauer R, Nyormoi O, Boyd D. Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2alpha-related factor. J Biol Chem. 1999 Feb 19; 274(8):4702-14. PMID: 9988707.
      Citations: 3     Fields:    Translation:Cells
    73. Simon C, Nemechek AJ, Boyd D, O'Malley BW, Goepfert H, Flaitz CM, Hicks MJ. An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion. Laryngoscope. 1998 Nov; 108(11 Pt 1):1686-91. PMID: 9818827.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    74. Gum R, Juarez J, Allgayer H, Mazar A, Wang Y, Boyd D. Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules. Oncogene. 1998 Jul 16; 17(2):213-25. PMID: 9674706.
      Citations: 6     Fields:    Translation:Cells
    75. Simon C, Goepfert H, Boyd D. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res. 1998 Mar 15; 58(6):1135-9. PMID: 9515796.
      Citations: 37     Fields:    Translation:HumansCells
    76. Nicolson GL, Nakajima M, Wakabayashi H, Boyd DD, Diaz D, Irimura T. Cancer cell heparanase activity associated with invasion and metastasis. Adv Enzyme Regul. 1998; 38:19-32. PMID: 9762344.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    77. Gohji K, Nakajima M, Boyd D, Dinney CP, Bucana CD, Kitazana S, Kamidono S, Fidler IJ. Organ-site dependence for the production of urokinase-type plasminogen activator and metastasis by human renal cell carcinoma cells. Am J Pathol. 1997 Dec; 151(6):1655-61. PMID: 9403716.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    78. Lengyel E, Wang H, Gum R, Simon C, Wang Y, Boyd D. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade. Oncogene. 1997 May 29; 14(21):2563-73. PMID: 9191056.
      Citations: 13     Fields:    Translation:Cells
    79. Gum R, Wang H, Lengyel E, Juarez J, Boyd D. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene. 1997 Mar 27; 14(12):1481-93. PMID: 9136992.
      Citations: 42     Fields:    Translation:HumansCells
    80. Mohanam S, Chintala SK, Go Y, Bhattacharya A, Venkaiah B, Boyd D, Gokaslan ZL, Sawaya R, Rao JS. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor. Oncogene. 1997 Mar 20; 14(11):1351-9. PMID: 9178895.
      Citations: 22     Fields:    Translation:HumansCells
    81. Simon C, Juarez J, Nicolson GL, Boyd D. Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion. Cancer Res. 1996 Dec 01; 56(23):5369-74. PMID: 8968087.
      Citations: 8     Fields:    Translation:HumansCells
    82. Lengyel E, Wang H, Stepp E, Juarez J, Wang Y, Doe W, Pfarr CM, Boyd D. Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene. J Biol Chem. 1996 Sep 20; 271(38):23176-84. PMID: 8798512.
      Citations: 19     Fields:    Translation:Cells
    83. Lengyel E, Gum R, Stepp E, Juarez J, Wang H, Boyd D. Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line. J Cell Biochem. 1996 Jun 01; 61(3):430-43. PMID: 8761947.
      Citations: 5     Fields:    Translation:HumansCells
    84. Gum R, Lengyel E, Juarez J, Chen JH, Sato H, Seiki M, Boyd D. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem. 1996 May 03; 271(18):10672-80. PMID: 8631874.
      Citations: 71     Fields:    Translation:HumansCells
    85. Boyd D. Invasion and metastasis. Cancer Metastasis Rev. 1996 Mar; 15(1):77-89. PMID: 8842480.
      Citations: 22     Fields:    Translation:Humans
    86. Lengye E, Singh B, Gum R, Nerlov C, Sabichi A, Birrer M, Boyd D. Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene. Oncogene. 1995 Dec 21; 11(12):2639-48. PMID: 8545121.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    87. Lengyel E, Stepp E, Gum R, Boyd D. Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras. J Biol Chem. 1995 Sep 29; 270(39):23007-12. PMID: 7559439.
      Citations: 14     Fields:    Translation:HumansCells
    88. Lengyel E, Klostergaard J, Boyd D. Stimulation of urokinase expression by TNF-alpha requires the activation of binding sites for the AP-1 and PEA3 transcription factors. Biochim Biophys Acta. 1995 Jul 20; 1268(1):65-72. PMID: 7626664.
      Citations: 4     Fields:    Translation:HumansCells
    89. Gum R, Wang SW, Lengyel E, Yu D, Hung MC, Juarez J, Boyd D. Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene. Anticancer Res. 1995 Jul-Aug; 15(4):1167-72. PMID: 7653995.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    90. Wang S, Boyd D. Modulation of urokinase-type plasminogen-activator expression by the wild-type and mutated p53 tumor-suppressor gene. Int J Oncol. 1995 Jul; 7(1):143-6. PMID: 21552819.
      Citations:    Fields:    
    91. Lengyel E, Gum R, Juarez J, Clayman G, Seiki M, Sato H, Boyd D. Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. Cancer Res. 1995 Feb 15; 55(4):963-7. PMID: 7850814.
      Citations: 18     Fields:    Translation:HumansCells
    92. Boyd DD, Nicolson GL. Mechanisms of invasion by head and neck cancers. Cancer Treat Res. 1995; 74:117-30. PMID: 7779611.
      Citations:    Fields:    Translation:HumansAnimals
    93. Wang H, Skibber J, Juarez J, Boyd D. Transcriptional activation of the urokinase receptor gene in invasive colon cancer. Int J Cancer. 1994 Sep 01; 58(5):650-7. PMID: 8077048.
      Citations: 8     Fields:    Translation:HumansCells
    94. Rao JS, Steck PA, Tofilon P, Boyd D, Ali-Osman F, Stetler-Stevenson WG, Liotta LA, Sawaya R. Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model. J Neurooncol. 1994; 18(2):129-38. PMID: 7964975.
      Citations: 24     Fields:    Translation:HumansCells
    95. Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D, Rao JS. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res. 1993 Sep 15; 53(18):4143-7. PMID: 8395977.
      Citations: 45     Fields:    Translation:HumansCells
    96. Juarez J, Clayman G, Nakajima M, Tanabe KK, Saya H, Nicolson GL, Boyd D. Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. Int J Cancer. 1993 Aug 19; 55(1):10-8. PMID: 7688350.
      Citations: 23     Fields:    Translation:HumansCells
    97. Karikó K, Kuo A, Boyd D, Okada SS, Cines DB, Barnathan ES. Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line. Cancer Res. 1993 Jul 01; 53(13):3109-17. PMID: 8391387.
      Citations: 16     Fields:    Translation:HumansCells
    98. Clayman G, Wang SW, Nicolson GL, el-Naggar A, Mazar A, Henkin J, Blasi F, Goepfert H, Boyd DD. Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity. Int J Cancer. 1993 Apr 22; 54(1):73-80. PMID: 8386710.
      Citations: 9     Fields:    Translation:HumansCells
    99. Hollas W, Hoosein N, Chung LW, Mazar A, Henkin J, Kariko K, Barnathan ES, Boyd D. Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines. Thromb Haemost. 1992 Dec 07; 68(6):662-6. PMID: 1337629.
      Citations: 14     Fields:    Translation:HumansCells
    100. Hollas W, Soravia E, Mazar A, Henkin J, Blasi F, Boyd D. Decreased urokinase receptor expression by overexpression of the plasminogen activator in a colon cancer cell line. Biochem J. 1992 Jul 15; 285 ( Pt 2):629-34. PMID: 1322138.
      Citations:    Fields:    Translation:Cells
    101. Hollas W, Boyd D. Regulation of the urokinase receptor by its plasminogen activator. Thromb Haemost. 1991 Dec 02; 66(6):678-83. PMID: 1665597.
      Citations: 1     Fields:    Translation:HumansCells
    102. Hoosein NM, Boyd DD, Hollas WJ, Mazar A, Henkin J, Chung LW. Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines. Cancer Commun. 1991 Aug; 3(8):255-64. PMID: 1653586.
      Citations: 24     Fields:    Translation:HumansCells
    103. Hollas W, Blasi F, Boyd D. Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res. 1991 Jul 15; 51(14):3690-5. PMID: 1648443.
      Citations: 33     Fields:    Translation:HumansCells
    104. Hollas W, Boyd D. Urokinase-dependent proteolysis in cultured colon cancer is directed by its receptor. Semin Thromb Hemost. 1991 Jul; 17(3):225-30. PMID: 1665585.
      Citations: 4     Fields:    Translation:HumansCells
    105. Schlechte W, Brattain M, Boyd D. Invasion of extracellular matrix by cultured colon cancer cells: dependence on urokinase receptor display. Cancer Commun. 1990; 2(5):173-9. PMID: 2164413.
      Citations: 12     Fields:    Translation:HumansCells
    106. Schlechte JW, Boyd DD. Insensitivity of laminin degradation directed by receptor bound urokinase to PAI-1 in cultured colon cancer. Cancer Commun. 1990; 2(8):261-9. PMID: 2390419.
      Citations:    Fields:    Translation:HumansCells
    107. Schlechte W, Murano G, Boyd D. Examination of the role of the urokinase receptor in human colon cancer mediated laminin degradation. Cancer Res. 1989 Nov 01; 49(21):6064-9. PMID: 2551498.
      Citations: 21     Fields:    Translation:HumansCells
    108. Boyd D. Examination of the effects of epidermal growth factor on the production of urokinase and the expression of the plasminogen activator receptor in a human colon cancer cell line. Cancer Res. 1989 May 01; 49(9):2427-32. PMID: 2539903.
      Citations: 8     Fields:    Translation:HumansCells
    109. Boyd D, Brattain M. Determination of the effects of epidermal growth factor on urokinase secretion and urokinase receptor display in a well-differentiated human colon carcinoma cell line. Cancer Res. 1989 Apr 15; 49(8):1948-53. PMID: 2539250.
      Citations: 2     Fields:    Translation:HumansCells
    110. Boyd D, Ziober B, Chakrabarty S, Brattain M. Examination of urokinase protein/transcript levels and their relationship with laminin degradation in cultured colon carcinoma. Cancer Res. 1989 Feb 15; 49(4):816-20. PMID: 2912554.
      Citations: 7     Fields:    Translation:HumansCells
    111. Boyd D, Florent G, Childress-Fields K, Brattain MG. Alteration in the behavior of a colon carcinoma cell line by extracellular matrix components. Cancer Lett. 1988 Jul; 41(1):81-90. PMID: 3164644.
      Citations: 2     Fields:    Translation:Cells
    112. Boyd D, Florent G, Murano G, Brattain M. Modulation of the urokinase receptor in human colon cell lines by N,N-dimethylformamide. Biochim Biophys Acta. 1988 Jun 08; 970(1):96-100. PMID: 2835992.
      Citations: 1     Fields:    Translation:HumansCells
    113. Boyd D, Florent G, Kim P, Brattain M. Determination of the levels of urokinase and its receptor in human colon carcinoma cell lines. Cancer Res. 1988 Jun 01; 48(11):3112-6. PMID: 2835152.
      Citations: 39     Fields:    Translation:HumansCells
    114. Boyd D, Florent G, Chakrabarty S, Brattain D, Brattain MG. Alterations of the biological characteristics of a colon carcinoma cell line by colon-derived substrata material. Cancer Res. 1988 May 15; 48(10):2825-31. PMID: 3162826.
      Citations: 8     Fields:    Translation:HumansCells
    115. Boyd DD, Levine AE, Brattain DE, McKnight MK, Brattain MG. Comparison of growth requirements of two human intratumoral colon carcinoma cell lines in monolayer and soft agarose. Cancer Res. 1988 May 01; 48(9):2469-74. PMID: 3281751.
      Citations: 26     Fields:    Translation:HumansCells
    116. Boyd D, Bialoski S, Brattain MG. The specific binding of transferrin to the murine fibroblast cell lines AKR-2B and its malignant counterpart AKR-MCA may be related to the transformed state. Cancer Lett. 1987 Sep; 36(3):263-71. PMID: 3652028.
      Citations:    Fields:    Translation:AnimalsCells
    117. Boyd D, Bialoski S, Brattain MG. Effects of difluoromethylornithine and dicyclohexylammonium sulfate on the transformed state of AKR-MCA cells. Cancer Res. 1987 Aug 01; 47(15):4099-104. PMID: 3111681.
      Citations:    Fields:    Translation:AnimalsCells
    118. Should Charity Air Medical Organizations Require Commercial Certification of Their Pilots?. Air Medical Journal. 34:188-194.
    119. Head and neck. Head and Neck. 23:1021-1023.
    120. Modulation of urokinase-type plasminogen activator expression by the wild-type and mutated p53 tumor suppressor gene. International Journal of Oncology. 7:143-146.
    121. First clinical evidence of a combined AP-2/Sp1 promoter motif as a tumor-specific activator of urokinase-receptor (u-PAR) expression in resected gastreintestinal cancers. European Journal of Cancer. 37.
    122. Plasminogen dependent laminin degradation and matrigel invasion by cultured colon cancer is directed by receptor-bound urokinase. Fibrinolysis and Proteolysis. 6:17-21.
    123. Divergent effect of n,n-dimethylformamide on the expression of urokinase and its receptor. Fibrinolysis and Proteolysis. 7:149-157.
    124. General aviation accidents related to exceedance of airplane weight/center of gravity limits. Accident Analysis and Prevention. 91:19-23.
    BOYD's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (503)
    Co-Authors (29)
    Similar People (60)
    Same Department Expand Description